Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985257 · ClinicalTrials.gov registry record · NA
Performance of a New Glucose Meter System in Children and Young Adults
A NA study of Diabetes, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 2
- Study locations
NCT00985257: Completed NA study of Diabetes, sponsored by Ascensia Diabetes Care.
NCT00985257 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 123 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00985257, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the performance of a new blood glucose meter in the hands of children, teens, young adults.
Primary Outcome
Subjects with diabetes and healthcare professionals (HCPs) used a new blood glucose monitoring system (BGMS) with subject blood. BGM results were compared to a lab glucose method - Yellow Springs Instrument (YSI) Analyzer. Duplicate BG results were used to calculate the number of BG results within +/-15mg/dL (for reference BG results \<75mg/dL) or +/- 20% (for reference BG values \>/=75mg/dL) of the reference method results.
Conditions Studied
Interventions
- DEVICE DIDGET (Investigational Blood Glucose Monitoring System)
Study Locations (2)
California
- AMCR Institute - Escondido
Florida
- Larry C. Deeb, MD PA - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00985257 record still lists
NCT00985257 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which DIDGET (Investigational Blood Glucose Monitoring System) is the first listed.
NCT00985257 reports a single indexed study location in California, Florida.
Frequently Asked Questions
What is clinical trial NCT00985257 about?
NCT00985257 is a clinical study titled "Performance of a New Glucose Meter System in Children and Young Adults". The purpose of this study is to evaluate the performance of a new blood glucose meter in the hands of children, teens, young adults.
What is the current status of trial NCT00985257?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2009-09. Estimated completion is 2009-10.
What conditions does trial NCT00985257 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT00985257?
The interventions under investigation include: DIDGET (Investigational Blood Glucose Monitoring System) (DEVICE).
Who is sponsoring clinical trial NCT00985257?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00985257 being conducted?
This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00985257's enrollment target sits among peer trials
123 181st of 338 higher than 158 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia